Cordlife Group Limited Stock

Equities

P8A

SG2E64980112

Healthcare Facilities & Services

Delayed Singapore S.E. 10:09:45 2024-04-24 pm EDT 5-day change 1st Jan Change
0.126 SGD 0.00% Intraday chart for Cordlife Group Limited -13.10% -60.00%
Sales 2021 56.67M 41.62M Sales 2022 55.16M 40.51M Capitalization 81.91M 60.16M
Net income 2021 6M 4.41M Net income 2022 4M 2.94M EV / Sales 2021 0.71 x
Net cash position 2021 61.98M 45.52M Net cash position 2022 63.75M 46.83M EV / Sales 2022 0.33 x
P/E ratio 2021
16.7 x
P/E ratio 2022
16.8 x
Employees 538
Yield 2021
2.25%
Yield 2022
-
Free-Float 31.7%
More Fundamentals * Assessed data
Dynamic Chart
1 day+3.28%
1 week-14.86%
Current month-26.74%
1 month-36.68%
3 months-58.00%
6 months-72.00%
Current year-60.00%
More quotes
1 week
0.12
Extreme 0.118
0.15
1 month
0.12
Extreme 0.118
0.21
Current year
0.12
Extreme 0.118
0.32
1 year
0.12
Extreme 0.118
0.57
3 years
0.12
Extreme 0.118
0.57
5 years
0.12
Extreme 0.118
0.63
10 years
0.12
Extreme 0.118
1.72
More quotes
Managers TitleAgeSince
Director of Finance/CFO 48 11-05-31
Chief Operating Officer - 13-02-28
Corporate Officer/Principal - -
Members of the board TitleAgeSince
Director/Board Member 68 18-05-21
Chairman 52 11-06-15
Director/Board Member 64 14-09-22
More insiders
Date Price Change Volume
24-04-24 0.126 0.00% 2 500
24-04-24 0.126 +3.28% 436,500
24-04-23 0.122 +1.67% 1,598,400
24-04-22 0.12 -2.44% 248,700
24-04-19 0.123 -15.17% 125,200

Delayed Quote Singapore S.E., April 24, 2024 at 04:50 am EDT

More quotes
Cordlife Group Limited is a Singapore-based company that owns cord blood banks in Asia with full stem cell banking facilities in Singapore, Hong Kong, Indonesia, the Philippines, India and Malaysia. The Company’s segments include Banking and Diagnostics. The banking segment comprises the collection, processing and banking of biological materials. The diagnostics segment comprises diagnostics testing services. Its banking services include cord blood, cord lining, cord lining mesenchymal stem cells, corneal lenticule, cord lining epithelial stem cells, cord tissue and others. Its diagnostic testing services include newborn genetic screening, pediatric vision screening, pediatric ear screening, pediatric allergen test, genetic talent test, preimplantation genetic screening, endometrial receptivity test, non-invasive prenatal testing and newborn metabolic screening. Its MOMS UP is a mobile app offering pregnancy, as well as parenting resources for moms and moms-to-be in Asia.
More about the company